Petros Pharmaceuticals, Inc. (PTPI) stock
PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026Market cap $135.07KP/E –Yield –
Petros Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Petros Pharmaceuticals's total debt was $4.92M at Sep 30, 2024. For fiscal 2023 it was $6.86M, down 18.2% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $6.86M | -18.2% |
| FY2022 | Dec 31, 2022 | $8.39M | +16.9% |
| FY2020 | Dec 31, 2020 | $7.18M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024 | Sep 30, 2024 | $4.92M | -32.1% |
| Q2 FY2024 | Jun 30, 2024 | $5.70M | -25.4% |
| Q1 FY2024 | Mar 31, 2024 | $6.46M | -19.4% |
| Q4 FY2023 | Dec 31, 2023 | $6.86M | -18.2% |
| Q3 FY2023 | Sep 30, 2023 | $7.25M | -17.2% |
| Q2 FY2023 | Jun 30, 2023 | $7.63M | -16.3% |
| Q1 FY2023 | Mar 31, 2023 | $8.01M | -15.4% |
| Q4 FY2022 | Dec 31, 2022 | $8.39M | +144.9% |
| Q3 FY2022 | Sep 30, 2022 | $8.76M | +73.0% |
| Q2 FY2022 | Jun 30, 2022 | $9.12M | +27.1% |
| Q1 FY2022 | Mar 31, 2022 | $9.48M | – |
| Q2 FY2021 | Jun 30, 2021 | $3.43M | – |
| Q1 FY2021 | Mar 31, 2021 | $5.06M | – |
| Q4 FY2020 | Dec 31, 2020 | $7.18M | – |
See a number that looks wrong?